{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:47:05Z","timestamp":1790182025132,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T00:00:00Z","timestamp":1199750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12016-007-8056-8","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T15:40:29Z","timestamp":1199720429000},"page":"300-306","source":"Crossref","is-referenced-by-count":16,"title":["Pathways to ANCA Production: From Differentiation of Dendritic Cells by Proteinase 3 to B Lymphocyte Maturation in Wegener\u2019s Granuloma"],"prefix":"10.1007","volume":"34","author":[{"given":"Elena","family":"Csernok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moosig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolgang L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,8]]},"reference":[{"key":"8056_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF01649318","volume":"69","author":"WL Gross","year":"1991","unstructured":"Gross WL, Csernok E, Schmitt WH (1991) Antineutrophil cytoplasmic autoantibodies: immunobiological aspects. Klin Wochenschr 69:558\u2013556","journal-title":"Klin Wochenschr"},{"key":"8056_CR2","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","volume":"52","author":"P Jagiello","year":"2005","unstructured":"Jagiello P, Aries P, Arning L et al (2005) The PTPN22 620W allele is a risk factor for Wegener\u2019s granulomatosis. Arthritis Rheum 52:4039\u20134043","journal-title":"Arthritis Rheum"},{"key":"8056_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/kel170","volume":"46","author":"YH Lee","year":"2007","unstructured":"Lee YH, Rho YH, Choi SJ et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases\u2014a meta-analysis. Rheumatology (Oxford) 46:49\u201356","journal-title":"Rheumatology (Oxford)"},{"key":"8056_CR4","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/art.21963","volume":"54","author":"KM Kaufman","year":"2006","unstructured":"Kaufman KM, Kelly JA, Herring BJ et al (2006) Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 54:2533\u20132540","journal-title":"Arthritis Rheum"},{"key":"8056_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","volume":"75","author":"AB Begovich","year":"2004","unstructured":"Begovich AB, Carlton VE, Honigberg LA et al (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330\u2013337","journal-title":"Am J Hum Genet"},{"key":"8056_CR6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ndt\/10.7.1162","volume":"10","author":"GD Nuyts","year":"1995","unstructured":"Nuyts GD, Van Vlem E, De Vos A et al (1995) Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol Dial Transplant 10:1162\u20131165","journal-title":"Nephrol Dial Transplant"},{"key":"8056_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","volume":"120","author":"CA Stegeman","year":"1994","unstructured":"Stegeman CA, Tervaert JW, Sluiter WJ et al (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120:12\u201317","journal-title":"Ann Intern Med"},{"key":"8056_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2006.08.005","volume":"6","author":"H Schultz","year":"2007","unstructured":"Schultz H (2007) From infection to autoimmunity: a new model for induction of ANCA against the bactericidal\/permeability increasing protein (BPI). Autoimmun Rev 6:223\u2013227","journal-title":"Autoimmun Rev"},{"key":"8056_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q","volume":"43","author":"HK Choi","year":"2000","unstructured":"Choi HK, Lamprecht P, Niles JL et al (2000) Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 43:226\u2013231","journal-title":"Arthritis Rheum"},{"key":"8056_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","volume":"10","author":"WF Pendergraft 3rd","year":"2004","unstructured":"Pendergraft WF 3rd, Preston GA, Shah RR et al (2004) Autoimmunity is triggered by cPR-3(105\u2013201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72\u201379","journal-title":"Nat Med"},{"key":"8056_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH656>3.0.CO;2-M","volume":"192","author":"A Mueller","year":"2000","unstructured":"Mueller A, Trabandt A, Gloeckner-Hofmann K et al (2000) Localized Wegener\u2019s granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 192:113\u2013120","journal-title":"J Pathol"},{"key":"8056_CR12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2005.044909","volume":"65","author":"J Voswinkel","year":"2006","unstructured":"Voswinkel J, Mueller A, Kraemer JA et al (2006) B lymphocyte maturation in Wegener\u2019s granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 65:859\u2013864","journal-title":"Ann Rheum Dis"},{"key":"8056_CR13","first-page":"S49","volume":"25","author":"P Lamprecht","year":"2007","unstructured":"Lamprecht P, Gross WL (2007) Current knowledge on cellular interactions in the WG-granuloma. Clin Exp Rheumatol 25:S49\u2013S51","journal-title":"Clin Exp Rheumatol"},{"key":"8056_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri976","volume":"3","author":"PH Plotz","year":"2003","unstructured":"Plotz PH (2003) The autoantibody repertoire: searching for order. Nat Rev Immunol 3:73\u201378","journal-title":"Nat Rev Immunol"},{"key":"8056_CR15","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","volume":"107","author":"E Csernok","year":"2006","unstructured":"Csernok E, Ai M, Gross WL, Wicklein D et al (2006) Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 107:4440\u20134448","journal-title":"Blood"},{"key":"8056_CR16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1164\/ajrccm.173.7.815a","volume":"173","author":"PM Aries","year":"2006","unstructured":"Aries PM, Lamprecht P, Gross WL (2006) Rituximab in refractory Wegener\u2019s granulomatosis: favorable or not? Am J Respir Crit Care Med 173:815\u2013816","journal-title":"Am J Respir Crit Care Med"},{"key":"8056_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.bor.0000200369.24793.f5","volume":"18","author":"B Hellmich","year":"2006","unstructured":"Hellmich B, Lamprecht P, Gross WL (2006) Advances in the therapy of Wegener\u2019s granulomatosis. Curr Opin Rheumatol 18:25\u201332","journal-title":"Curr Opin Rheumatol"},{"key":"8056_CR18","first-page":"125","volume":"39","author":"C Geffriaud-Ricouard","year":"1993","unstructured":"Geffriaud-Ricouard C, Noel LH, Chauveau D et al (1993) Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 39:125\u2013136","journal-title":"Clin Nephrol"},{"key":"8056_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/40.2.178","volume":"40","author":"U Schoenermarck","year":"2001","unstructured":"Schoenermarck U, Lamprecht P, Csernok E et al (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40:178\u2013184","journal-title":"Rheumatology (Oxford)"},{"key":"8056_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, van Houwelingen HC et al (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80\u201389","journal-title":"Kidney Int"},{"key":"8056_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/08916930701357208","volume":"40","author":"S Michlewska","year":"2007","unstructured":"Michlewska S, McColl A, Rossi AG et al (2007) Clearance of dying cells and autoimmunity. Autoimmunity 40:267\u2013273","journal-title":"Autoimmunity"},{"key":"8056_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1196\/annals.1358.015","volume":"1062","author":"WD Duan-Porter","year":"2005","unstructured":"Duan-Porter WD, Casciola-Rosen L, Rosen A (2005) Autoantigens: the critical partner in initiating and propagating systemic autoimmunity. Ann N Y Acad Sci 1062:127\u2013136","journal-title":"Ann N Y Acad Sci"},{"key":"8056_CR23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.184.6.2231","volume":"184","author":"HM Gilligan","year":"1996","unstructured":"Gilligan HM, Bredy B, Brady HR et al (1996) Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 184:2231\u20132241","journal-title":"J Exp Med"},{"key":"8056_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2249.2000.01410.x","volume":"122","author":"F Moosig","year":"2000","unstructured":"Moosig F, Csernok E, Kumanovics G et al (2000) Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol 122:499\u2013503","journal-title":"Clin Exp Immunol"},{"key":"8056_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9440(10)64532-4","volume":"157","author":"L Harper","year":"2000","unstructured":"Harper L, Ren Y, Savill J, Adu D et al (2000) Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 157:211\u2013220","journal-title":"Am J Pathol"},{"key":"8056_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1523-1755.2002.00161.x","volume":"61","author":"R Kettritz","year":"2002","unstructured":"Kettritz R, Scheumann J, Xu Y et al (2002) TNF-alpha-accelerated apoptosis abrogates ANCA-mediated neutrophil respiratory burst by a caspase-dependent mechanism. Kidney Int 61:502\u2013515","journal-title":"Kidney Int"},{"key":"8056_CR27","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1681\/ASN.V1281764","volume":"12","author":"YC Patry","year":"2001","unstructured":"Patry YC, Trewick DC, Gregoire M et al (2001) Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12:1764\u20131768","journal-title":"J Am Soc Nephrol"},{"key":"8056_CR28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","volume":"2","author":"CG Kallenberg","year":"2006","unstructured":"Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2:661\u2013670","journal-title":"Nat Clin Pract Rheumatol"},{"key":"8056_CR29","first-page":"131","volume":"151","author":"P Heeringa","year":"1997","unstructured":"Heeringa P, Foucher P, Klok PA et al (1997) Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut. Am J Pathol 151:131\u2013140","journal-title":"Am J Pathol"},{"key":"8056_CR30","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2217::AID-IMMU2217>3.0.CO;2-P","volume":"28","author":"JM Harper","year":"1998","unstructured":"Harper JM, Thiru S, Lockwood CM et al (1998) Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL\/Mp-lpr\/lpr mice: a spontaneous model for human microscopic angiitis. Eur J Immunol 28:2217\u20132226","journal-title":"Eur J Immunol"},{"key":"8056_CR31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/art.1780381004","volume":"38","author":"Y Tomer","year":"1995","unstructured":"Tomer Y, Gilburd B, Blank M et al (1995) Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum 38:1375\u20131381","journal-title":"Arthritis Rheum"},{"key":"8056_CR32","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1016\/j.febslet.2005.08.056","volume":"579","author":"O Wiesner","year":"2005","unstructured":"Wiesner O, Litwiller RD, Hummel AM et al (2005) Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 579:5305\u20135312","journal-title":"FEBS Lett"},{"key":"8056_CR33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955\u2013963","journal-title":"J Clin Invest"},{"issue":"86","key":"8056_CR34","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","volume":"106","author":"MA Little","year":"2005","unstructured":"Little MA, Smyth CL, Yadav R, Ambrose L, Coock HT, Nourshargh S, Pusey CD (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106(86):2050\u20132058","journal-title":"Blood"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8056-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-8056-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8056-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:41:58Z","timestamp":1630471318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-8056-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,8]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["8056"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8056-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,8]]}}}